中财网 中财网股票行情
恩华药业(002262)财务分析指标    年份：
截止日期2024-03-312023-12-312023-09-302023-06-302023-03-31
营业总收入(万元)135756.57504150.45365598.52240032.88117880.65
营业收入(万元)135756.57504150.45365598.52240032.88117880.65
营业总成本(万元)106692.73396039.62269274.46177412.2293429.44
营业成本(万元)39670.69136984.3198315.8663018.1331440.37
净利润(万元)26528.22103056.9288564.1354470.3022742.94
归属于母公司的净利润(万元)26528.22103691.8188564.1354470.3022742.94
营业利润(万元)30487.13118234.42100545.6962609.2026157.96
利润总额(万元)29973.61116864.41100077.4862198.9825849.97
少数股东损益(万元)-64.35-267.08-222.66-29.46-225.60
基本每股收益(元)0.26(元)1.03(元)0.88(元)0.54(元)0.23(元)
稀释每股收益(元)0.26(元)1.03(元)0.88(元)0.54(元)0.23(元)
非经常性损益(万元)-200.412384.30-2.21---177.07
扣除非经常性损益后净利润(万元)26728.64101307.5188566.3454525.5422920.02
总资产(万元)760395.48732819.54713916.52683064.30681526.85
总负债(万元)92920.8491808.7787251.2090299.61100533.90
归属于母公司股东权益合计(万元)669942.37643414.15630637.23596543.40584967.80
股东权益合计(万元)667474.64641010.77626665.32592764.69580992.95
实收资本(股本)(万元)100758.81100758.81100758.81100758.81100758.81
资本公积(万元)10298.5810298.5811941.0411941.0411941.04
未分配利润(万元)507830.14481301.91466247.65432153.82420578.22
经营活动产生的现金流量净额(万元)23358.23100830.0081864.8844574.4536439.58
经营活动现金流入小计(万元)146640.08539148.90405573.01263387.97138399.77
经营活动现金流出小计(万元)123281.85438318.90323708.13218813.52101960.18
投资活动产生的现金流量净额(万元)-67352.19-29339.09-6782.8519469.25-38761.16
投资活动现金流入小计(万元)101172.57653422.82480095.03398198.01189355.01
投资活动现金流出小计(万元)168524.75682761.91486877.89378728.76228116.17
筹资活动产生的现金流量净额(万元)195.10-21017.37-22655.57-21553.11903.08
筹资活动现金流入小计(万元)2000.008000.004000.002500.002500.00
筹资活动现金流出小计(万元)1804.9029017.3726655.5724053.111596.92
期末现金及现金等价物余额(万元)157175.40200961.28202665.40192939.55149029.61
最后修改日期2024-04-202024-04-012023-10-262023-07-312023-04-17
↑返回页顶↑

转至恩华药业（002262）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。